A Randomized Noninferiority Trial To Determine the Optimum Dose of Radioiodine for Remnant Ablation in Differentiated Thyroid Cancer

被引：0
|
作者：
Bal, C. S. [1 ]
Chandra, P. [1 ]
Kumar, A. [1 ]
Dwivedi, S. N. [1 ]
机构：
[1] All India Inst Med Scis, New Delhi, India
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1675 / S1675
页数：1
相关论文
共 50 条
  • [31] Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer
    Pacini, Furio
    EUROPEAN THYROID JOURNAL, 2016, 5 (01) : 7 - +
  • [32] The HiLo trial: A multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer
    Mallick, U.
    Harmer, C.
    Hackshaw, A.
    CLINICAL ONCOLOGY, 2008, 20 (05) : 325 - 326
  • [33] Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
    Fallahi, Babak
    Beiki, Davood
    Takavar, Abbas
    Fard-Esfahani, Armaghan
    Gilani, Kianoush Ansari
    Saghari, Mohsen
    Eftekhari, Mohammad
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (03) : 275 - 282
  • [34] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    Castagna, M. G.
    Cantara, S.
    Pacini, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1087 - 1094
  • [35] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    M. G. Castagna
    S. Cantara
    F. Pacini
    Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094
  • [36] Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma
    Taube, A
    Lundell, G
    CANCER, 1997, 79 (01) : 190 - 190
  • [37] Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma
    Bal, C
    Padhy, AK
    Jana, S
    Pant, GS
    Basu, AK
    CANCER, 1996, 77 (12) : 2574 - 2580
  • [38] Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything?
    Forleo, R.
    Fralassi, N.
    Maino, F.
    Capezzone, M.
    Brilli, L.
    Pilli, T.
    Cantara, S.
    Castagna, M. G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (01) : 139 - 144
  • [39] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01): : 121 - 128
  • [40] Low-activity Radioiodine for Remnant Ablation after Surgery for Differentiated Thyroid Cancer-Initial Experience
    Sobral Violante, L. C.
    Teixeira, J.
    Sampaio, I.
    Martins, R.
    Couto, J.
    Fonseca, A.
    Costa, L.
    Lopes, F.
    Soares, O.
    Duarte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S503 - S504
12345